Recent Quotes
My Watchlist
Indicators
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY:LLY)

1,015.21 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Feb 11, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,165
Open 1,015.21
Bid (Size) 1,021.70 (40)
Ask (Size) 1,030.00 (40)
Prev. Close 1,015.21
Today's Range 1,015.21 - 1,015.21
52wk Range 623.78 - 1,133.95
Shares Outstanding 956,580,893
Dividend Yield 0.59%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Eli Lilly vs Novo Nordisk in the Weight Loss Drug Market: Here's What Investors Need to Know. ↗
Both companies are betting on interest in weight loss pills. 
Via The Motley Fool
News headline image
1 Cash-Producing Stock with Competitive Advantages and 2 That Underwhelm
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities. 
Via StockStory

Performance

YTD
-6.0%
-6.0%
1 Month
-6.1%
-6.1%
3 Month
-0.3%
-0.3%
6 Month
+53.7%
+53.7%
1 Year
+17.4%
+17.4%

More News

Read More
News headline image
I Predicted That ExxonMobil Would Join the $1 Trillion Club by 2030, But the Stock Is Already Up 24% in 2026. Is the High-Yield Dividend Stock Still a Buy Now? ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
VKTX Stock Rallies After Hours On Optimism Around Company’s Obesity Pipeline ↗
Via Stocktwits
News headline image
Novo Nordisk Reportedly Eyes Launching Wegovy In Vials To Compete With Rival Eli Lilly ↗
Via Stocktwits
Topics Intellectual Property
News headline image
3 Reasons to Buy Eli Lilly Stock ↗
Via The Motley Fool
Topics Government
News headline image
Disney Has Its Next CEO ↗
Via The Motley Fool
News headline image
Healthcare Stocks Are Sinking. Here Are 2 to Buy on the Dip. ↗
Via The Motley Fool
News headline image
Biotech Beat Nvidia in 2025. Can It Do It Again? ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Incyte (INCY) Deep Dive: Navigating the 2026 Crossroads Following Earnings Miss
Via Finterra
Topics Economy Intellectual Property
News headline image
Viking Therapeutics: The Under‑the‑Radar GLP‑1 Contender Growth Hunters Can't Ignore ↗
Via The Motley Fool
News headline image
The Top 5 Analyst Questions From Eli Lilly’s Q4 Earnings Call
Via StockStory
Topics Earnings
News headline image
Zoetis (ZTS) Reports Q4: Everything You Need To Know Ahead Of Earnings
Via StockStory
Topics Artificial Intelligence
News headline image
Organon Earnings: What To Look For From OGN
Via StockStory
Topics Artificial Intelligence World Trade
News headline image
Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon. ↗
Via The Motley Fool
News headline image
2 Vanguard ETFs That Could Turn $400 Per Month Into $1 Million ↗
Via The Motley Fool
Topics ETFs
News headline image
Thinking About Investing in GLP-1 Stocks? Here Are 3 Things You Need to Know ↗
Via The Motley Fool
News headline image
AstraZeneca Signals a New Era in Obesity Care: Earnings Report Teases Oral GLP-1 Powerhouse
Via MarketMinute
Topics Artificial Intelligence Earnings Economy
News headline image
The $80 Billion Ambition: An In-Depth Analysis of AstraZeneca (AZN) in 2026
Via Finterra
Topics Artificial Intelligence Economy Fraud
News headline image
Hoth Therapeutics's GDNF Treatment Shows Superior Efficacy Over Wegovy, Ozempic In Preclinical Trial ↗
Via Stocktwits
News headline image
The Vertical Integration of Wellness: A Deep Dive into Hims & Hers Health (HIMS)
Via Finterra
Topics Artificial Intelligence Intellectual Property Lawsuit
News headline image
Eli Lilly Is Partnering with Gene-Editing Start-up Seamless Therapeutics. Here's What Investors Need to Know. ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Could Eli Lilly Turn Today's GLP‑1 Obesity Boom Into Multi‑Decade, Millionaire‑Maker Gains? ↗
Via The Motley Fool
News headline image
What To Expect From Royalty Pharma’s (RPRX) Q4 Earnings
Via StockStory
Topics World Trade
News headline image
Novo Nordisk vs. Eli Lilly: What's the Better Long-Term Investment? ↗
Via The Motley Fool
Topics Intellectual Property

Frequently Asked Questions

Is Eli Lilly publicly traded?
Yes, Eli Lilly is publicly traded.
What exchange does Eli Lilly trade on?
Eli Lilly trades on the New York Stock Exchange
What is the ticker symbol for Eli Lilly?
The ticker symbol for Eli Lilly is LLY on the New York Stock Exchange
What is the current price of Eli Lilly?
The current price of Eli Lilly is 1,015.21
When was Eli Lilly last traded?
The last trade of Eli Lilly was at 02/11/26 07:00 PM ET
What is the market capitalization of Eli Lilly?
The market capitalization of Eli Lilly is 971.13B
How many shares of Eli Lilly are outstanding?
Eli Lilly has 971B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.